Form 8-K - Current report:
SEC Accession No. 0001193125-25-004063
Filing Date
2025-01-10
Accepted
2025-01-10 07:00:51
Documents
39
Period of Report
2025-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820907d8k.htm   iXBRL 8-K 43580
2 EX-10.1 d820907dex101.htm EX-10.1 10119
3 EX-10.2 d820907dex102.htm EX-10.2 16218
4 EX-99.1 d820907dex991.htm EX-99.1 31996
5 EX-99.2 d820907dex992.htm EX-99.2 26955
9 GRAPHIC g820907ex10_1.jpg GRAPHIC 18979
10 GRAPHIC g820907g11g11.jpg GRAPHIC 147116
11 GRAPHIC g820907g12g12.jpg GRAPHIC 219908
12 GRAPHIC g820907g13g13.jpg GRAPHIC 151222
13 GRAPHIC g820907g14g14.jpg GRAPHIC 159397
14 GRAPHIC g820907g15g15.jpg GRAPHIC 175811
15 GRAPHIC g820907g16g16.jpg GRAPHIC 149576
16 GRAPHIC g820907g17g17.jpg GRAPHIC 146434
17 GRAPHIC g820907g18g18.jpg GRAPHIC 137546
18 GRAPHIC g820907g19g19.jpg GRAPHIC 145274
19 GRAPHIC g820907g20g20.jpg GRAPHIC 164550
20 GRAPHIC g820907g21g21.jpg GRAPHIC 167352
21 GRAPHIC g820907g22g22.jpg GRAPHIC 163928
22 GRAPHIC g820907g23g23.jpg GRAPHIC 89641
23 GRAPHIC g820907g24g24.jpg GRAPHIC 206085
24 GRAPHIC g820907g25g25.jpg GRAPHIC 227191
25 GRAPHIC g820907g26g26.jpg GRAPHIC 177763
26 GRAPHIC g820907g27g27.jpg GRAPHIC 218386
27 GRAPHIC g820907g28g28.jpg GRAPHIC 177644
28 GRAPHIC g820907g29g29.jpg GRAPHIC 173257
29 GRAPHIC g820907g30g30.jpg GRAPHIC 127232
30 GRAPHIC g820907g31g31.jpg GRAPHIC 29616
  Complete submission text file 0001193125-25-004063.txt   4932594

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA spro-20250107.xsd EX-101.SCH 2868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20250107_lab.xml EX-101.LAB 17994
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20250107_pre.xml EX-101.PRE 11273
42 EXTRACTED XBRL INSTANCE DOCUMENT d820907d8k_htm.xml XML 3677
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 25520344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)